Immunosuppression followed by hematopoietic stem cell transplant has shown potent, long-lasting efficacy for relapsing multiple sclerosis in early studies. Now comes a six-year phase 3 trial.Read More
Cleveland Clinic’s Kidney Transplant Program had another landmark year, completing nearly 230 kidney transplants — the most the program has performed in a single year to date. Alvin Wee, MD, Surgical Director of Renal Transplantation Program, discusses three strategic initiatives that supported this achievement.
In fall 2019, Cleveland Clinic was the first hospital in the world to successfully perform a robotic single-port kidney transplant. CQD talks to main campus perioperative nurse manager about what it takes to have a successful robotic surgery program.
A new study challenges existing guidelines for staging melanomas of the lower genital tract. In this article, the researchers discuss the similarities found in the molecular structure and survival outcomes of vulvar and vaginal melanomas.
Cardiac magnetic resonance imaging offers strong prognostic value in the setting of ischemic cardiomyopathy by quantifying how infarct size interacts with mitral regurgitation severity. So finds a new study.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
The need for advanced practice registered nurses (APRNs) is growing. The field offers great opportunities, and completing a program can take as little as 18 months. This infographic shows the areas of practice and the education needed.
Neel Parekh, MD, a Cleveland Clinic urologist and male fertility specialist, discusses a study he recently co-authored that takes a scientific look at the clinical utility of male fertility supplements.
Clinical trials of TRIKAFTA demonstrated robust improvement in pulmonary function in patients with cystic fibrosis. In this article, pediatric pulmonologist Nathan Kraynack, MD, shares his early experience with the new, game-changing regimen.
Insulin-dependent patients with type 2 diabetes and obesity have significantly higher healthcare expenditures. A recent study stratifies these high-cost, high-need patients who might benefit most from interventions and medical weight loss management.
Most patients with cardiac implantable electronic devices lacked some degree of basic knowledge of their device in a Cleveland Clinic study. They also reported a desire to use more of their device’s data features.